277 related articles for article (PubMed ID: 11094089)
1. Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination.
Nakamura S; Roth JA; Mukhopadhyay T
Mol Cell Biol; 2000 Dec; 20(24):9391-8. PubMed ID: 11094089
[TBL] [Abstract][Full Text] [Related]
2. Multiple lysine mutations in the C-terminus of p53 make it resistant to degradation mediated by MDM2 but not by human papillomavirus E6 and induce growth inhibition in MDM2-overexpressing cells.
Nakamura S; Roth JA; Mukhopadhyay T
Oncogene; 2002 Apr; 21(16):2605-10. PubMed ID: 11971195
[TBL] [Abstract][Full Text] [Related]
3. MDM2 can promote the ubiquitination, nuclear export, and degradation of p53 in the absence of direct binding.
Inoue T; Geyer RK; Howard D; Yu ZK; Maki CG
J Biol Chem; 2001 Nov; 276(48):45255-60. PubMed ID: 11572869
[TBL] [Abstract][Full Text] [Related]
4. Identification of p53 sequence elements that are required for MDM2-mediated nuclear export.
Gu J; Nie L; Wiederschain D; Yuan ZM
Mol Cell Biol; 2001 Dec; 21(24):8533-46. PubMed ID: 11713288
[TBL] [Abstract][Full Text] [Related]
5. The conformationally flexible S9-S10 linker region in the core domain of p53 contains a novel MDM2 binding site whose mutation increases ubiquitination of p53 in vivo.
Shimizu H; Burch LR; Smith AJ; Dornan D; Wallace M; Ball KL; Hupp TR
J Biol Chem; 2002 Aug; 277(32):28446-58. PubMed ID: 11925449
[TBL] [Abstract][Full Text] [Related]
6. MDM2 mediates p300/CREB-binding protein-associated factor ubiquitination and degradation.
Jin Y; Zeng SX; Lee H; Lu H
J Biol Chem; 2004 May; 279(19):20035-43. PubMed ID: 14769800
[TBL] [Abstract][Full Text] [Related]
7. Multiple C-terminal lysine residues target p53 for ubiquitin-proteasome-mediated degradation.
Rodriguez MS; Desterro JM; Lain S; Lane DP; Hay RT
Mol Cell Biol; 2000 Nov; 20(22):8458-67. PubMed ID: 11046142
[TBL] [Abstract][Full Text] [Related]
8. MDM2-dependent ubiquitination of nuclear and cytoplasmic P53.
Yu ZK; Geyer RK; Maki CG
Oncogene; 2000 Nov; 19(51):5892-7. PubMed ID: 11127820
[TBL] [Abstract][Full Text] [Related]
9. [Nuclear import of p53 in relation to MDM2-mediated degradation and ubiquitination].
Li HP; Zhang YP
Zhonghua Zhong Liu Za Zhi; 2005 Feb; 27(2):86-9. PubMed ID: 15946545
[TBL] [Abstract][Full Text] [Related]
10. Regulation of p53 nuclear export through sequential changes in conformation and ubiquitination.
Nie L; Sasaki M; Maki CG
J Biol Chem; 2007 May; 282(19):14616-25. PubMed ID: 17371868
[TBL] [Abstract][Full Text] [Related]
11. C-terminal ubiquitination of p53 contributes to nuclear export.
Lohrum MA; Woods DB; Ludwig RL; Bálint E; Vousden KH
Mol Cell Biol; 2001 Dec; 21(24):8521-32. PubMed ID: 11713287
[TBL] [Abstract][Full Text] [Related]
12. Defective p53 post-translational modification required for wild type p53 inactivation in malignant epithelial cells with mdm2 gene amplification.
Knights CD; Liu Y; Appella E; Kulesz-Martin M
J Biol Chem; 2003 Dec; 278(52):52890-900. PubMed ID: 14555661
[TBL] [Abstract][Full Text] [Related]
13. MdmX protects p53 from Mdm2-mediated degradation.
Jackson MW; Berberich SJ
Mol Cell Biol; 2000 Feb; 20(3):1001-7. PubMed ID: 10629057
[TBL] [Abstract][Full Text] [Related]
14. Nucleocytoplasmic shuttling of p53 is essential for MDM2-mediated cytoplasmic degradation but not ubiquitination.
O'Keefe K; Li H; Zhang Y
Mol Cell Biol; 2003 Sep; 23(18):6396-405. PubMed ID: 12944468
[TBL] [Abstract][Full Text] [Related]
15. The MDM2 RING-finger domain is required to promote p53 nuclear export.
Geyer RK; Yu ZK; Maki CG
Nat Cell Biol; 2000 Sep; 2(9):569-73. PubMed ID: 10980696
[TBL] [Abstract][Full Text] [Related]
16. A site-directed mutagenesis study of the MdmX RING domain.
Egorova O; Mis M; Sheng Y
Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
[TBL] [Abstract][Full Text] [Related]
17. Stabilization and activation of p53 by the coactivator protein TAFII31.
Buschmann T; Lin Y; Aithmitti N; Fuchs SY; Lu H; Resnick-Silverman L; Manfredi JJ; Ronai Z; Wu X
J Biol Chem; 2001 Apr; 276(17):13852-7. PubMed ID: 11278372
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of p53 degradation by Mdm2 acetylation.
Wang X; Taplick J; Geva N; Oren M
FEBS Lett; 2004 Mar; 561(1-3):195-201. PubMed ID: 15013777
[TBL] [Abstract][Full Text] [Related]
19. Mdm2 mutant defective in binding p300 promotes ubiquitination but not degradation of p53: evidence for the role of p300 in integrating ubiquitination and proteolysis.
Zhu Q; Yao J; Wani G; Wani MA; Wani AA
J Biol Chem; 2001 Aug; 276(32):29695-701. PubMed ID: 11340074
[TBL] [Abstract][Full Text] [Related]
20. Biological significance of a small highly conserved region in the N terminus of the p53 tumour suppressor protein.
Liu WL; Midgley C; Stephen C; Saville M; Lane DP
J Mol Biol; 2001 Nov; 313(4):711-31. PubMed ID: 11697899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
